Found: 11
Select item for more details and to access through your institution.
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial.
- Published in:
- Helicobacter, 2024, v. 29, n. 4, p. 1, doi. 10.1111/hel.13121
- By:
- Publication type:
- Article
Electronically Modulated FeNi Composite by CeO<sub>2</sub> Porous Nanosheets for Water Splitting at Large Current Density.
- Published in:
- Journal of Electrochemistry, 2023, v. 29, n. 5, p. 1, doi. 10.13208/j.electrochem.2208121
- By:
- Publication type:
- Article
Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2020, v. 47, n. 11, p. 1783, doi. 10.1111/1440-1681.13375
- By:
- Publication type:
- Article
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
- Published in:
- Digestion, 2023, v. 104, n. 4, p. 249, doi. 10.1159/000529622
- By:
- Publication type:
- Article
Can the optimal treatment duration be determined in bismuth-containing therapies for Helicobacter pylori eradication?
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 4037, doi. 10.1007/s10238-023-01099-w
- By:
- Publication type:
- Article
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 4, p. 1033, doi. 10.1007/s10238-022-00953-7
- By:
- Publication type:
- Article
Efficacy and safety of a 14‐day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 12, p. 2097, doi. 10.1111/jgh.16348
- By:
- Publication type:
- Article
Vonoprazan is noninferior to proton pump inhibitors in bismuth‐containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysis.
- Published in:
- Journal of Digestive Diseases, 2023, v. 24, n. 1, p. 19, doi. 10.1111/1751-2980.13166
- By:
- Publication type:
- Article
Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross‐sectional survey.
- Published in:
- Journal of Digestive Diseases, 2022, v. 23, n. 7, p. 365, doi. 10.1111/1751-2980.13119
- By:
- Publication type:
- Article
Implementation of WeChat‐based patient–doctor interaction in the management of Helicobacter pylori infection: A propensity score matching analysis.
- Published in:
- Journal of Digestive Diseases, 2022, v. 23, n. 5, p. 280, doi. 10.1111/1751-2980.13114
- By:
- Publication type:
- Article
Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 7, p. 2540, doi. 10.1007/s10620-024-08460-3
- By:
- Publication type:
- Article